BR112021019314A2 - Compostos inibitórios de 5-ht2b de serotonina - Google Patents

Compostos inibitórios de 5-ht2b de serotonina

Info

Publication number
BR112021019314A2
BR112021019314A2 BR112021019314A BR112021019314A BR112021019314A2 BR 112021019314 A2 BR112021019314 A2 BR 112021019314A2 BR 112021019314 A BR112021019314 A BR 112021019314A BR 112021019314 A BR112021019314 A BR 112021019314A BR 112021019314 A2 BR112021019314 A2 BR 112021019314A2
Authority
BR
Brazil
Prior art keywords
serotonin
ht2b
inhibitory compounds
compounds
heart failure
Prior art date
Application number
BR112021019314A
Other languages
English (en)
Portuguese (pt)
Inventor
Govindan Subramanian
Jinxia, (Nancy) Deng
Andrew Ewin Richard
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of BR112021019314A2 publication Critical patent/BR112021019314A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR112021019314A 2019-03-28 2020-03-26 Compostos inibitórios de 5-ht2b de serotonina BR112021019314A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962825051P 2019-03-28 2019-03-28
PCT/US2020/024969 WO2020198478A1 (en) 2019-03-28 2020-03-26 Serotonin 5-ht2b inhibitory compounds

Publications (1)

Publication Number Publication Date
BR112021019314A2 true BR112021019314A2 (pt) 2021-12-14

Family

ID=70775466

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021019314A BR112021019314A2 (pt) 2019-03-28 2020-03-26 Compostos inibitórios de 5-ht2b de serotonina

Country Status (13)

Country Link
US (2) US12240827B2 (https=)
EP (1) EP3947360B1 (https=)
JP (1) JP7454589B2 (https=)
CN (1) CN113631548B (https=)
AU (1) AU2020245614B2 (https=)
BR (1) BR112021019314A2 (https=)
CA (1) CA3134952C (https=)
DK (1) DK3947360T3 (https=)
ES (1) ES2991167T3 (https=)
FI (1) FI3947360T3 (https=)
PL (1) PL3947360T3 (https=)
PT (1) PT3947360T (https=)
WO (1) WO2020198478A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240027076A (ko) * 2021-07-26 2024-02-29 조에티스 서비시즈 엘엘씨 세로토닌 5-ht2b 억제 화합물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0515995D0 (en) 2005-08-03 2005-09-07 Sandoz Ag Organic compounds
WO2007097197A1 (ja) * 2006-02-20 2007-08-30 Astellas Pharma Inc. アミド誘導体またはその塩
TWI415845B (zh) 2006-10-03 2013-11-21 Arena Pharm Inc 用於治療與5-ht2a血清素受體相關聯病症之作為5-ht2a血清素受體之調節劑的吡唑衍生物
JP2012512877A (ja) * 2008-12-18 2012-06-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング セロトニン5−ht2b受容体阻害剤
US8697739B2 (en) 2010-07-29 2014-04-15 Novartis Ag Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof

Also Published As

Publication number Publication date
US20220162183A1 (en) 2022-05-26
US12240827B2 (en) 2025-03-04
PL3947360T3 (pl) 2024-11-04
CA3134952A1 (en) 2020-10-01
EP3947360A1 (en) 2022-02-09
AU2020245614A1 (en) 2021-10-14
US20250179046A1 (en) 2025-06-05
JP2022527080A (ja) 2022-05-30
JP7454589B2 (ja) 2024-03-22
DK3947360T3 (da) 2024-08-26
WO2020198478A8 (en) 2021-09-16
ES2991167T3 (es) 2024-12-02
CA3134952C (en) 2023-08-08
CN113631548A (zh) 2021-11-09
FI3947360T3 (fi) 2024-10-07
CN113631548B (zh) 2023-06-06
EP3947360B1 (en) 2024-08-07
WO2020198478A1 (en) 2020-10-01
AU2020245614B2 (en) 2023-01-19
PT3947360T (pt) 2024-09-20

Similar Documents

Publication Publication Date Title
IL288104A (en) Heterocyclic compounds, preparation methods and uses thereof
MX2022004937A (es) Inhibidores de las cinasas raf.
AU2018338314A1 (en) Protein degraders and uses thereof
JOP20200209A1 (ar) مثبطات cd73
EA202090572A1 (ru) ИНГИБИТОРЫ Rho-АССОЦИИРОВАННОЙ, СОДЕРЖАЩЕЙ СУПЕРСПИРАЛЬ ПРОТЕИНКИНАЗЫ
EA201800444A1 (ru) Производные майтанзиноида, их конъюгаты и способы использования
CY1124088T1 (el) Παραγωγα 2,4-θειαζολιδινεδιονης στη θεραπεια διαταραχων του κεντρικου νευρικου συστηματος
BR112017009671A2 (pt) inibidores de ezh2 e usos destes
BR112016017041A2 (pt) Proteína isolada tendo atividade de fosfatase, polinucleotídeo, vetor, célula hospedeira, método para produzir uma proteína e composição
EP3674314A3 (en) Apelin polypeptides
LT3962601T (lt) 5-ht2a agonistai, skirti panaudoti depresijos gydymui
MX381487B (es) Ciertos inhibidores de la proteina quinasa.
CL2021000426A1 (es) Inhibidores de la interacción proteína-proteína keap1-nrf2.
EA202191180A1 (ru) Производные конденсированного гетероциклического бензодиазепина и их применение
EA202192101A1 (ru) Соединения и их применение
MX2022002056A (es) Compuestos para el tratamiento de enfermedad respiratoria bovina o porcina.
EA201692474A1 (ru) Производные 1-(циклопент-2-ен-1-ил)-3-(2-гидрокси-3-(арилсульфонил)фенил)мочевины в качестве ингибиторов cxcr2
EA202191058A1 (ru) Антитела против муцина-16 и способы их применения
BR112019005183A2 (pt) sistema paratransgênico inovador para o biocontrole de mosquitos transmissores de doença
EP3714885A4 (en) COMPOSITION WITH CYCLO (HIS-PRO) (CHP) FOR THE PREVENTION, RELIEF OR TREATMENT OF BONE DISEASES
BR112018009745A8 (pt) compostos heterocíclicos para o tratamento de doença
EA202192786A1 (ru) Твердые формы (e)-3-[2-(2-тиенил)винил]-1h-пиразола
MX2021002652A (es) Uso de inhibidores de caseina-cinasa 1 para el tratamiento de enfermedades vasculares.
BR112021019314A2 (pt) Compostos inibitórios de 5-ht2b de serotonina
DK3762000T3 (da) Anvendelse af direkte tilførte mikrobielle midler til forebyggelse og/eller behandling af infektioner, der forårsages af e. coli, hos dyr

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]